Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • VALEANT PHARMACEUTICALS INTL Analyst Recommendations

  • Analyst Consensus: VRX

    First Call Consensus Recommendation

    • Strong Buy1
    • Buy2
    • Hold3
    • Sell4
    • Strong Sell5
    Mean Analyst Consensus Recommendation Analysts Reporting
    Current Recommendation 3.571 Underperform 7
    30 Days Ago 3.857 Underperform 7
    60 Days Ago 4.000 Underperform 8
    90 Days Ago 4.000 Underperform 8
    120 Days Ago 3.857 Underperform 7

  • Analyst Ratings: VRX

    Brokerage Firm Previous Rating Current Rating Change Date Price Target
    Leerink Swann Outperform Mkt Perform 07/09/2009 —
    Piper Jaffray — Underweight 07/07/2009 18.00
    Wachovia Mkt Perform Underperform 06/09/2009 —
    Ladenburg Thalmann — Neutral 05/14/2009 18.00
    Soleil — Sell 05/14/2009 14.00
    Leerink Swann — Outperform 03/24/2009 —
    Brean Murray — Sell 10/28/2008 9.00
    Lazard Capital Sell Hold 09/23/2008 —
    Lazard Capital — Sell 05/14/2008 9.00
    Lazard Capital Hold Sell 03/17/2008 8.00
    Bear Stearns Underperform Peer Perform 02/13/2008 —
    Friedman Billings Mkt Perform — 02/08/2008 —
    Bear Stearns Peer Perform Underperform 11/05/2007 —
    Friedman Billings Outperform Mkt Perform 11/01/2007 14.00
    Friedman Billings — Outperform 06/21/2007 22.00
    Lazard Captial Buy Hold 09/13/2006 —
    Friedman Billings — Mkt Perform 07/13/2006 17.00
    Bear Stearns — Peer Perform 04/28/2006 —
    Piper Jaffray Outperform Market Perform 04/04/2006 17.00
    Piper Jaffray — Outperform 01/21/2005 34.00
    Merrill Lynch — Buy 10/18/2004 32.00
    Wells Fargo Sec — Hold 01/28/2004 —